INTERNATIONAL PATENT: MIRATI THERAPEUTICS, INC. FILES APPLICATION FOR "THE USE OF SON OF SEVENLESS (SOS) INHIBITOR COMPOUNDS SUCH AS 7-SUBSTITUTED BENZOFURANS TO TREAT CANCER"

GENEVA, May 6 -- MIRATI THERAPEUTICS, INC. (Route 206 and Province Line RoadPrinceton, New Jersey 08543) filed a patent application (PCT/US2025/052155) for "THE USE OF SON OF SEVENLESS (SOS) INHIBITOR COMPOUNDS SUCH AS 7-SUBSTITUTED BENZOFURANS TO TREAT CANCER" on Oct 23, 2025. With publication no. WO/2026/090348, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KUEHLER, Jon Edward (c/o Mirati Therapeutics, Inc.Route 206 and Province Line RoadPrinceton, New Jersey 08543), IVETAC, Anthony David (c/o Mirati Therapeutics, Inc...